# Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

> **NCT01369628** · PHASE1 · TERMINATED · sponsor: **EMD Serono** · enrollment: 1 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Atacicept

## Key facts

- **NCT ID:** NCT01369628
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2011-11
- **Final completion:** —
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Please see Purpose Statement below
- **Last updated:** 2013-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01369628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01369628, "Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01369628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*